Kamran Siminou
Executive Chairman & Founder @ NeurOptics
Kamran Siminou is a seed investor at NeurOptics focused on Men's and Medical.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kamran Siminou invests in
Stages Kamran Siminou invests in
Countries Kamran Siminou invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Men's 1 (100%)
- Medical 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Butterfly Medical
|
Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can beplaced in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe.Visit www.butterfly-medical.com for more information. | $2M / Seed / Jan 29, 2020 |
About NeurOptics
NeurOptics manufactures devices that gather and process information from the human eye to support medical decision-making and researches. The company believes that the eyes are also windows into the human body and offer a glimpse into important physiological information for clinicians in a noninvasive manner. They make devices which-collect andprocess information from the human eye to facilitate medical decision making and enable clinical research.NeurOptics develops and markets innovative technologies facilitating improved medical decision making and enabling clinical research in critical care medicine, neurology, neurosurgery, emergency medicine, ophthalmology, and research. It was founded in 1995 and is headquartered in Laguna Hills, CA, USA.
NeurOptics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kamran Siminou
Executive Chairman & Founder
|
|||
|
William Worthen
President and Chief Executive Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Kamran Siminou invest in?
Kamran Siminou invests primarily in Men's, Medical and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kamran Siminou?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kamran Siminou last invest?
The most recent investment recorded for Kamran Siminou closed in Jan 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
